CORT
Corcept Therapeutics Incorporated
116.10$
-2.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +50.0% | +32.4% | +220.8% | +41.3% | +32.3% | +38.7% | -25.9% | +37.7% | +6.5% | +35.2% | -0.5% | |
| – | +62.0% | +34.1% | +114.0% | +71.1% | +27.8% | +70.6% | -49.2% | +87.4% | -8.1% | +2.8% | +2.9% | |
| – | +66.8% | +27.5% | +101.8% | +98.8% | -84.9% | +1,425.1% | -83.7% | -14.5% | +104.4% | -5.8% | -5.6% | |
| – | +66.8% | +27.5% | +101.8% | +98.8% | +33.5% | +72.8% | -53.1% | +93.1% | -14.7% | +4.1% | -2.9% | |
| – | +86.6% | +58.5% | +186.0% | -37.6% | +13.3% | +31.5% | +10.8% | +61.4% | +21.3% | +2.2% | +2.9% | |
| – | +39.4% | +38.5% | +259.6% | +93.9% | -66.6% | +290.1% | -76.4% | +22.3% | +26.7% | +60.6% | +3.7% | |
| – | -58.5% | +109.2% | +152.7% | +26.4% | +60.3% | +59.5% | -40.2% | +77.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -12.0% | -18.1% | +8.0% | +21.1% | +14.8% | +17.7% | -0.9% | +70.2% | +40.7% | +40.2% | +17.3% | |
| – | +54.0% | +31.1% | +8.0% | +21.1% | +8.5% | -72.8% | +350.5% | +52.5% | +44.2% | +34.7% | +18.0% | |
| – | +58.8% | -2.0% | – | – | – | +31.6% | -74.3% | +117.3% | -86.8% | +449.0% | +30.8% | |
| – | -29.7% | +72.8% | +274.6% | -3.6% | -8.8% | +40.0% | -34.5% | +73.4% | +45.3% | -11.6% | +163.0% | |
| – | -48.6% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | +123.7% | +361.5% | +44.5% | +34.5% | +41.0% | -28.2% | +33.5% | +1.0% | +34.1% | -4.7% | |
| – | – | – | – | – | – | – | +136.5% | +52.0% | +35.8% | +35.1% | +18.3% | |
| – | +5.8% | +8.7% | +7.2% | +1.7% | -3.3% | +1.3% | +1.4% | -7.9% | -3.6% | +1.6% | +5.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.